The invention as claimed herein relates to synergistic combinations of nucleoside analogues, which are converted to viral DNA polymerase inhibitors through the action of at least one virus-induced enzyme, and thiosemicarbazone ribonucleotide reductase inhibitors. These combinations are especially useful in combatting herpes virus infections.
                            本发明涉及核苷类似物与
硫代
氨基甲酸核糖核苷酸还原酶
抑制剂的协同组合,核苷类似物可通过至少一种病毒诱导酶的作用转化为病毒 
DNA 聚合酶抑制剂。 这些组合尤其有助于防治疱疹病毒感染。